Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. radiological
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Radiological Articles & Analysis

228 news found

Dosimetry monitoring with the RiumBox: Protect the health of healthcare workers in hospital settings

Dosimetry monitoring with the RiumBox: Protect the health of healthcare workers in hospital settings

As a result, 28 beacons have been installed in various departments (radiology, operating theatres, and scanners rooms), enabling real-time monitoring of ionizing radiation and reinforcing the surveillance of workers exposed to low doses of radiation, using more sensitive tools that are independent of being worn by the personnel. ...

ByBertin Technologies


RTI celebrates record-breaking year!

RTI celebrates record-breaking year!

RTI Group, a global leader in Quality Assurance (QA) of X-ray imaging, proudly announces a landmark year marked by exceptional financial performance, significant market expansion, and strategic innovations. The company exceeded its revenue target, achieving over 125 million SEK in 2024, representing a remarkable growth of more than 20 percent compared to the previous ...

ByRTI Group AB


RTI Calibration Laboratory Achieves ISO 17025 Accreditation for Half Value Layer (HVL) Calibration

RTI Calibration Laboratory Achieves ISO 17025 Accreditation for Half Value Layer (HVL) Calibration

We are proud to announce that the RTI Calibration Laboratory in Mölndal, Sweden, has officially achieved ISO 17025 accreditation for Half Value Layer (HVL) calibration. This milestone allows us to expand our services, offering customers accredited HVL calibration alongside our existing ISO 17025 accredited calibrations for Tube Voltage, Air Kerma, mA/mAs, Luminance, and ...

ByRTI Group AB


AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

The study is led by co-Principal Investigators William Brent Keeling, MD, Associate Professor of Surgery, Department of Surgery, at the Emory University School of Medicine, and Immediate Past President, The PERT Consortium™ and Mona Ranade, MD, Assistant Professor, Interventional Radiology, at the David Geffen School of Medicine at UCLA. “Data from the APEX-AV study ...

ByAngioDynamics, Inc.


Bayer expands global clinical program for darolutamide in prostate cancer

Bayer expands global clinical program for darolutamide in prostate cancer

The primary endpoint of this study is radiological progression-free survival (rPFS), measured by PSMA PET/CT assessed by independent central review. ...

ByBayer AG


Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced today that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from ...

ByBayer AG


How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

Advancements In AI Support The Detection Of PC AI brings added support for experts in radiology as they detect, classify and characterize PC lesions via scan assessments. ...

ByLifespin GmbH


Bayer completes acquisition of Blackford Analysis Ltd.

Bayer completes acquisition of Blackford Analysis Ltd.

“Today’s official closing of the acquisition of Blackford marks an important step in implementing our strategy to drive innovation in radiology, including the development and adoption of AI within the clinical workflow,” said Gerd Krüger, President Radiology, Bayer. ...

ByBayer AG


Ultravist by Bayer now approved for contrast-enhanced mammography in EU

Ultravist by Bayer now approved for contrast-enhanced mammography in EU

The approval expands Bayer’s radiology portfolio, which includes contrast media, injectors as well as digital and artificial intelligence (AI) enabled solutions, supporting radiologists across a broad range of diseases including breast cancer. ...

ByBayer AG


Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division. “This acquisition complements our ...

ByBayer AG


Inspirata Accelerates Its Growth as a Leading Provider of AI/NLP Technology in Oncology Informatics

Inspirata Accelerates Its Growth as a Leading Provider of AI/NLP Technology in Oncology Informatics

” “Acquiring Inspirata’s digital pathology business allows Fujifilm to be an even stronger healthcare partner – bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise,” says Teiichi Goto, President and CEO, representative director, FUJIFILM ...

ByInspirata, Inc


BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

Department of Health and Human Services, provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases. ...

ByLumen Bioscience, Inc.


Antengene Highlights Encouraging ATG-008 Efficacy Results From TORCH-2 Study in Combination with PD-1 Antibody in Relapsed/Metastatic Cervical Cancer

Antengene Highlights Encouraging ATG-008 Efficacy Results From TORCH-2 Study in Combination with PD-1 Antibody in Relapsed/Metastatic Cervical Cancer

ATG-008 was administered daily until radiological disease progression (according to RECIST 1.1 criteria) or intolerable toxicity. ...

ByAntengene Corporation Limited


Ready to go mobile

Ready to go mobile

The Arktis Radiation Detectors MODES kit is designed to detect and identify radiological threats. The system can work either deployed in vehicles or as a stand-alone static monitor. ...

ByArktis Radiation Detectors Ltd.


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

INTRODUCTION Gabriel Krestin received his MD from the University of Cologne, Germany where he also specialized in radiology, in 1981 and his PhD (Habilitation) in 1989. From 1990–1997, he worked at the University Hospital in Zürich/CH, including a period as acting chairman of the Department of Radiology. In 1997 he moved to Erasmus MC in Rotterdam, ...

ByFluidda


SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...

BySIGA Technologies, Inc.


Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

The funding is provided by BARDA to support the advanced research and development of medical countermeasures (MCM) for chemical, biological, radiological and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases that threaten the U.S. civilian population. ...

ByEnalare Therapeutics Inc.


SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®

SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®

SIGA has been collaborating with the DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to develop the Post Exposure Prophylaxis (PEP) indication for oral TPOXX, and this work is supported by a separate development contract worth approximately $26 million (Contract number: MCDC1901-001-2019-400). ...

BySIGA Technologies, Inc.


ScreenPoint Medical showcases world leading Transpara powered by FusionAI at RSNA

ScreenPoint Medical showcases world leading Transpara powered by FusionAI at RSNA

It follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities both across the US and in over 25 countries worldwide. The success of FDA cleared Transpara AI has been marked by a record number of peer reviewed papers and well over 2,000,000 mammograms being read by this unique system. Transpara's developers, ScreenPoint Medical is ...

ByScreenPoint Medical


Integrating Fusion Biopsies into Your Practice II

Integrating Fusion Biopsies into Your Practice II

Targeted MRI-US fusion biopsy is an emerging technology with the potential to change the standard of care for diagnosis and treatment. It combines the accuracy of MRI with the real-time monitoring of ultrasound to detect more clinically significant cancer, while preventing unnecessary biopsies. Unlike standard systematic biopsy, fusion can track lesions over time with imaging or repeat ...

ByFocal Healthcare

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT